商务合作
动脉网APP
可切换为仅中文
Future Market Insights, Inc. (FMI) reveals a surging advanced therapeutics pharmaceutical outsourcing market, propelled by cutting-edge treatments and the crucial role of specialized partners. Gene therapies, cell therapies, mRNA breakthroughs, and personalized medicine drive the need for expert support.
Future Market Insights,Inc.(FMI)揭示了由尖端治疗和专业合作伙伴的关键作用推动的激增的先进治疗药物外包市场。基因疗法,细胞疗法,mRNA突破和个性化医学推动了对专家支持的需求。
Explore full report for insights & stakeholder opportunities..
浏览完整报告以获取见解和利益相关者机会。。
NEWARK, Del., Jan. 16, 2024 /PRNewswire/ -- Future Market Insights (FMI)' latest industry analysis shows that the Global Advanced Therapeutics Pharmaceutical Outsourcing Market was valued at US$ 7,197.8 million in 2023. The market is projected to reach US$ 11,698.1 million, surging at a CAGR of 4.4% by 2034..
新泽西州纽瓦克(NEWARK,Del.),2024年1月16日/PRNewswire/--未来市场洞察(FMI)的最新行业分析显示,2023年全球先进治疗药物外包市场的价值为71.978亿美元。预计该市场将达到1169810万美元,到2034年,复合年增长率将达到4.4%。。
Request Exclusive Sample Report: Advanced Therapeutics Pharmaceutical Outsourcing Industry Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-18755
请求独家样本报告:Advanced Therapeutics制药外包行业战略见解,https://www.futuremarketinsights.com/reports/sample/rep-gb-18755
Advanced therapeutics encompass a range of cutting-edge and innovative treatments, including gene therapies, cell therapies, mRNA-based therapies, and other personalized and precision medicine approaches. Pharmaceutical companies often collaborate with external partners, such as contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) service providers, to leverage their expertise, infrastructure, and capabilities in the complex and rapidly evolving field of advanced therapeutics..
先进的治疗方法包括一系列前沿和创新的治疗方法,包括基因疗法,细胞疗法,基于mRNA的疗法以及其他个性化和精准医学方法。制药公司通常与外部合作伙伴(如合同开发和制造组织(CDMO)和合同研究组织(CRO)服务提供商)合作,以利用其在复杂且快速发展的先进治疗领域的专业知识,基础设施和能力。。
The advanced therapeutics pharmaceutical outsourcing market is propelled by an array of drivers and opportunities that underscore its pivotal role in the dynamic landscape of advanced therapeutic development. Rapid advancements in gene therapy, cell therapy, and mRNA technologies are catalysts for outsourcing services, demanding specialized expertise to navigate their complexities. .
先进治疗药物外包市场是由一系列驱动因素和机会推动的,这些驱动因素和机会强调了其在先进治疗发展的动态格局中的关键作用。基因治疗,细胞治疗和mRNA技术的快速发展是外包服务的催化剂,需要专业知识来应对其复杂性。。
The escalating pipeline of innovative therapies, especially those targeting rare diseases and oncology, provides a fertile ground for outsourcing partners to offer indispensable support in development and manufacturing. The globalization of clinical trials, driven by the trend toward personalized medicine, particularly in oncology, further amplifies the demand for outsourcing services with a global reach..
不断升级的创新疗法,特别是针对罕见疾病和肿瘤学的疗法,为外包合作伙伴提供了肥沃的土壤,为开发和制造提供不可或缺的支持。在个性化医疗(尤其是肿瘤学)趋势的推动下,临床试验的全球化进一步扩大了对全球范围外包服务的需求。。
Technological innovations in manufacturing, such as continuous manufacturing and automation, present opportunities for outsourcing partners to enhance efficiency and scalability in producing advanced therapeutics. Strategic collaborations and partnerships between pharmaceutical companies, academic institutions, and outsourcing entities foster innovation and collectively address challenges in the rapidly evolving field. .
制造业的技术创新,如连续制造和自动化,为外包合作伙伴提供了机会,以提高生产先进疗法的效率和可扩展性。制药公司、学术机构和外包实体之间的战略合作和伙伴关系促进了创新,并共同应对快速发展领域的挑战。。
As the market evolves, opportunities lie in expanding outsourcing services to cover a broader spectrum of advanced therapeutic modalities, meeting pharmaceutical clients' diverse and dynamic needs.
随着市场的发展,机会在于扩大外包服务,以涵盖更广泛的先进治疗方式,满足制药客户多样化和动态的需求。
Scope of the Report
报告的范围
Attribute
属性
Details
详细信息
Estimated Market Size (2024)
预计市场规模(2024年)
US$ 7,592.8 million
75.928亿美元
Projected Market Size (2034)
预计市场规模(2034年)
US$ 11,698.1 million
1169810万美元
Anticipated Growth Rate (2024 to 2034)
预期增长率(2024年至2034年)
4.4 %
4.4 %
Forecast Period
预测期
2024 to 2034
2024年至2034年
Historical Data Available for
历史数据可用于
2019 to 2023
2019年至2023年
Market Analysis
市场分析
US$ million for Value
价值百万美元
Key Countries Covered
涵盖的主要国家
United States
美国
Canada
加拿大
Mexico
墨西哥
Brazil
巴西
Chile
智利
China
中国
Japan
日本
Poland
波兰
South Korea
韩国
Germany
德国
France
法国
Spain
西班牙
Italy
意大利
BENELUX
比荷卢
Nordic Countries
北欧国家
United Kingdom
英国
BENELUX
比荷卢
Hungary
匈牙利
Romania
罗马尼亚
India
印度
Association of Southeast Asian Nations Countries
东南亚国家联盟国家
Australia and New Zealand
澳大利亚和新西兰
GCC Countries
海湾合作委员会国家
South Africa
南非
Türkiye
蒂尔基耶
Key Market Segments Covered
涵盖的主要细分市场
Advanced Therapeutics Pharmaceutical Outsourcing Industry Segmentation By Service Type:
按服务类型划分的高级治疗药物外包行业细分:
Contract Research Organizations (CROs)
合同研究组织(CRO)
Contract Development and Manufacturing Organizations (CDMOs)
合同开发和制造组织(CDMO)
By Indication:
根据指示:
Oncology
肿瘤学
Neurology
神经病学
Cardiology
心脏病学
Infectious Diseases
传染病
Others
其他
By Therapy:
通过治疗:
Cell Therapy
细胞疗法
Gene Therapy
基因治疗
RNA-based Therapies
基于RNA的疗法
Others
其他
By Phases:
分阶段:
Preclinical Services
临床前服务
Clinical Services
临床服务
Commercial Manufacturing and Packaging
商业制造和包装
By Region:
按地区:
North America
北美
Latin America
拉丁美洲
East Asia
东亚
South Asia and Pacific
南亚和太平洋
Western Europe
西欧
Eastern Europe
东欧
Middle East and Africa
中东和非洲
Key Companies Profiled
主要公司简介
Croda International Plc
禾大国际股份有限公司
Charles River Laboratories International, Inc.
查尔斯河实验室国际有限公司。
Catalent, Inc.
Catalent公司。
QuintilesIMS (IQVIA)
QuintilesIMS(IQVIA)
Parexel International Corporation
Parexel国际公司
ICON plc
图标plc
PPD, Inc. (Thermo Fisher Scientific)
PPD公司(Thermo Fisher Scientific)
LabCorp (Laboratory Corporation of America Holdings)
LabCorp(美国实验室控股公司)
Syneos Health
Syneos运行状况
WuXi AppTec
药明康德
Lonza Group
龙沙集团
Piramal Pharma Solutions
Piramal Pharma解决方案
SGS SA
SGS-SA
Evotec SE
Evotec SE
CMC Biologics (Now AGC Biologics)
CMC Biologics(现为AGC Biologics)
Marken (A UPS Company)
Marken(UPS公司)
Cytovance Biologics
Cytovance Biologics
Samsung Biologics
三星生物制品
CordenPharma
科登制药
Recipharm AB
Recipharm AB
Vetter Pharma International GmbH
Vetter Pharma International GmbH
Cryoport Systems, Inc.
Cryoport系统公司。
ProPharma Group
ProPharma集团
Fujifilm Diosynth Biotechnologies
富士薄膜Diosynch生物技术
Medpace
Medspace
Novotech Pty Ltd.
Novotech私人有限公司。
Axcella Health Inc.
Axcella Health Inc。
CelerionAshland
阿什兰
Purchase this report now to get key companies with their Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis.
立即购买此报告,以获取关键公司的收入预测、销量预测、公司排名、竞争格局、增长因素、趋势和定价分析。
Key Takeaways from the Market Study
市场研究的主要收获
By service type, contract development and manufacturing organizations (CDMOs) are expected to surge at a CAGR of surge at a CAGR of 3.7% by 2034.
根据服务类型,到2034年,合同开发和制造组织(CDMO)预计将以3.7%的复合年增长率激增。
By indication, oncology held a 46.1% market value share in 2023.
根据指示,肿瘤学在2023年拥有46.1%的市场价值份额。
By therapy, gene therapy held the leading share in the market of 49.6% in 2023.
通过治疗,基因治疗在2023年的市场份额为49.6%。
By phases, commercial manufacturing, and packaging segment dominates with the leading share, accounting for 54.9% in 2023.
分阶段来看,商业制造和包装部门占主导地位,2023年占54.9%。
North America is the primary region, holding a substantial value share of 37.3% in 2023.
北美是主要地区,2023年拥有37.3%的实质价值份额。
'Development and manufacturing of advanced therapeutics, such as gene and cell therapies, is responsible for the growth of the advanced therapeutics pharmaceutical outsourcing market worldwide,' says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).
Sabyasachi Ghosh(Future market Insights,Inc.)副总裁)说,基因和细胞疗法等先进疗法的开发和制造是全球先进疗法药物外包市场增长的原因。
Competitive Landscape
竞争格局
The advanced therapeutics pharmaceutical outsourcing market encourages collaborative innovation, with pharmaceutical companies and outsourcing partners working together to advance technologies, overcome challenges, and bring novel therapies to market.
先进治疗药物外包市场鼓励合作创新,制药公司和外包合作伙伴共同努力推进技术,克服挑战,并将新疗法推向市场。
For instance,
例如,
In June 2023, KD Pharma Group and DUDE CHEM announced their strategic partnership to usher in a new era of digital innovation, greatly enhancing the efficiency and safety of pharmaceutical drug and therapy development.
2023年6月,KD Pharma Group和DUDE CHEM宣布建立战略合作伙伴关系,开创数字创新的新时代,极大地提高了药物和治疗开发的效率和安全性。
In January 2021, Thermo Fisher Scientific, Inc. acquired the viral vector business from Henogen S.A (Groupe Novasep SAS).
2021年1月,Thermo Fisher Scientific,Inc.从Henogen S.A(Groupe Novasep SAS)收购了病毒载体业务。
Want more insights?
想要更多见解?
Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2019 to 2034. The global advanced therapeutics pharmaceutical outsourcing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader..
Future Market Insights提供了一份关于全球、地区和国家层面收入增长预测的综合研究报告,并对2019年至2034年各细分市场的最新行业趋势进行了分析。全球先进治疗药物外包市场进行了详细细分,涵盖了市场的各个方面,并为读者提供了完整的市场情报方法。。
The study provides compelling insights into the advanced therapeutics pharmaceutical outsourcing market segment based on service type – (contract research organizations (CROs), contract development and manufacturing organizations (CDMOs)), indication (oncology, neurology, cardiology, infectious diseases, others), therapy (cell therapy, gene therapy, RNA-based therapies, others) phases (preclinical services, clinical services, commercial manufacturing, and packaging) across seven major regions..
该研究根据服务类型(合同研究组织(CRO),合同开发和制造组织(CDMO)),适应症(肿瘤学,神经病学,心脏病学,传染病等)对先进治疗药物外包市场细分提供了令人信服的见解,七个主要地区的治疗(细胞治疗,基因治疗,基于RNA的治疗等)阶段(临床前服务,临床服务,商业制造和包装)。。
Request to Access the Detail Research Methodology from here!
请从此处访问详细的研究方法!
About Healthcare Division at Future Market Insights (FMI)
关于未来市场洞察力(FMI)的医疗保健部门
Future Market Insights (FMI) facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you to devise innovation-driven trajectories for your business.
未来市场洞察力(FMI)有助于医疗保健行业的企业、政府、投资者和相关受众识别并强调适用于产品战略、监管环境、技术演变和其他关键问题的关键方面,以实现可持续的成功。我们收集市场情报的独特方法使您能够为您的业务设计创新驱动的轨迹。
Know more about our sector coverage here..
更多了解我们在这里的行业覆盖范围。。
About the Author:
关于作者:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Sabyasachi Ghosh(Future Market Insights,Inc.副总裁)在医疗保健、医疗器械和制药行业拥有超过12年的经验。他的好奇心和分析能力帮助他塑造了自己的研究生涯。
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation..
他自然会发现客户面临的关键挑战,并设计出稳健、基于假设的解决方案,赋予他们战略决策能力。他的主要专长是市场进入和扩张战略、可行性研究、竞争情报和战略转型等领域。。
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
拥有微生物学学位的Sabyasachi撰写了许多出版物,并在包括《mHealth杂志》、《ITN Online》和《脊柱外科新闻》在内的期刊上被引用。
Explore FMI's Extensive Coverage in the Healthcare Domain:
探索FMI在医疗保健领域的广泛覆盖范围:
Vitamin and Mineral Supplement Market by Vitamins and Minerals, from 2024 to 2034. – Review and Request to Access the Sample PDF.
2024年至2034年维生素和矿物质补充剂市场查看并请求访问示例PDF。
Infection Prevention Market Forecast by Consumables and Disinfectors Products from 2024 to 2034. - Review and Request to Access the Sample PDF.
2024年至2034年消耗品和消毒剂产品的感染预防市场预测查看并请求访问示例PDF。
Distance Health Technology Market Analysis by Telemedicine Hardware and Software from 2024 to 2034. - Review and Request to Access the Sample PDF.
2024年至2034年远程医疗硬件和软件的远程医疗技术市场分析查看并请求访问示例PDF。
Topical Pain Relief Market Analysis by Creams, Gels, Patch, and Spray Formulations, 2024 to 2034. - Review and Request to Access the Sample PDF.
2024年至2034年乳膏、凝胶、贴剂和喷雾制剂的局部止痛市场分析查看并请求访问示例PDF。
Baby Safety Products Market by Product Type, Distribution Channel & Region | Forecast 2023 to 2033. - Review and Request to Access the Sample PDF.
按产品类型、分销渠道和地区划分的婴儿安全产品市场|预测2023年至2033年-查看并请求访问示例PDF。
About Future Market Insights (FMI)
关于未来市场洞察力(FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the United Kingdom, the United States, and India. FMI's latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition..
Future Market Insights(FMI)是市场情报和咨询服务的领先提供商,为150多个国家的客户提供服务。FMI总部位于迪拜,在英国、美国和印度设有交付中心。FMI最新的市场研究报告和行业分析有助于企业应对挑战,并在激烈的竞争中自信而清晰地做出关键决策。。
Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers..
我们的定制和联合市场研究报告提供了可行的见解,推动了可持续增长。FMI的一支由专家领导的分析师团队不断跟踪广泛行业的新兴趋势和事件,以确保我们的客户为其消费者不断变化的需求做好准备。。
Contact UsNandini Singh SawlaniFuture Market Insights Inc.Christiana Corporate, 200 Continental Drive,Suite 401, Newark, Delaware - 19713, USAT: +1-845-579-5705For Sales Enquiries: [email protected]Website: https://www.futuremarketinsights.comLinkedIn | Twitter | Blogs | YouTube
联系UsNandini Singh SawlaniFuture Market Insights Inc.Christiana Corporate,200 Continental Drive,Suite 401,Newark,Delaware-19713,USAT:+1-845-579-5705销售咨询:[受电子邮件保护]网站:https://www.futuremarketinsights.comLinkedIn|推特|博客| YouTube
Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg
标志:https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg
SOURCE Future Market Insights
获取未来市场见解